Cargando…
Angiotensin II administration to COVID-19 patients is not advisable
Autor principal: | Speth, Robert C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274512/ https://www.ncbi.nlm.nih.gov/pubmed/32503621 http://dx.doi.org/10.1186/s13054-020-03032-z |
Ejemplares similares
-
Statistical advising: Professional development opportunities for the biostatistician
por: LeBlanc, Marissa, et al.
Publicado: (2022) -
Why Angiotensin II is a Poor Choice for Circulatory Support of Ventilated COVID-19 Patients Compared to Vasopressin
por: Speth, Robert C., et al.
Publicado: (2022) -
Four Principles to Consider Before Advising Women on Screening Mammography
por: Keen, John D., et al.
Publicado: (2015) -
Avoid clinical inertia: Importance of asking and advising patients with diabetes who smoke about quitting
por: Yatsuya, Hiroshi
Publicado: (2020) -
Deaf Children Need Rich Language Input from the Start: Support in Advising Parents
por: Humphries, Tom, et al.
Publicado: (2022)